Immunity to glycan α-Gal and possibilities for the control of COVID-19 - Archive ouverte HAL Access content directly
Journal Articles Immunotherapy Year : 2021

Immunity to glycan α-Gal and possibilities for the control of COVID-19

(1, 2) , (1) , (3)
1
2
3

Abstract

"Despite the advances and potential impact that new vaccines represent for the prevention and control of COVID-19, interventions boosting the immune response to alpha-Gal with a broader and not pathogen-specific immunity may contribute not only to the control of COVID-19 but also to potential re-infections by SARS-CoV-2-related genetic variants or other pathogens that negatively affect the individual response to SARS-CoV-2."

Dates and versions

hal-03943467 , version 1 (17-01-2023)

Identifiers

Cite

José De La Fuente, Christian Gortázar, Alejandro Cabezas-Cruz. Immunity to glycan α-Gal and possibilities for the control of COVID-19. Immunotherapy, 2021, 13 (3), pp.185-188. ⟨10.2217/imt-2020-0247⟩. ⟨hal-03943467⟩

Collections

ANSES ENVA INRAE
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More